Response Robert Kadlec News Today

A former HHS official revealed what he believes may be the real origin of COVID-19 after he and Dr. Fauci downplayed the lab leak theory.

Three days after Beijing officially acknowledged a cluster of an unknown pneumonia disease in 2020, then-head of the ...

The issue was exacerbated by workers leaving food at their desks while they largely worked from home the past two years.

POLITICO Get the POLITICO Pulse newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Presented by Editor’s Note: POLITICO Pulse is a free version of POLITICO Pro Health Cares morning newsletter, which is delivered to our subsc...

J&J vaccine production could restart in U.S. within days, Emergent executive testifies POLITICO 5 hrs ago By Sarah Owermohle © Stefani Reynolds/The New York Times via AP, Pool Robert Kramer, president and CEO of Emergent BioSolutions, speaks via videoconference during a hearing on Capitol Hill. Emergent BioSolutions could resume manufacturing Johnson & Johnsons Covid-19 vaccine within days, CEO Robert Kramer told a House panel Wednesday. The Food and Drug Administration ord...

By Reuters Staff 2 Min Read (Reuters) - The U.S. government will buy 1.25 million additional doses of Regeneron Pharmaceuticals’ COVID-19 antibody cocktail for about $2.63 billion, bringing the total supply of the treatment to more than 1.5 million doses. FILE PHOTO: The Regeneron Pharmaceuticals company logo is seen on a building at the companys Westchester campus in Tarrytown, New York, U.S. September 17, 2020. REUTERS/Brendan McDermid/File Photo The cocktail, a combination of two antibodie...